Form 4: GE HealthCare Director Anne Madden Receives Stock Award
Director Compensation Disclosure
Director Anne T. Madden acquired 5,868 shares of GE HealthCare common stock through restricted and deferred stock unit awards.
Summary
- Director Anne T. Madden received 3,586 restricted stock units (RSUs) vesting on the earlier of the next annual meeting or May 7, 2027.
- Director Madden received 2,282 fully vested deferred stock units in lieu of a cash retainer.
- The total beneficial ownership for the director increased to 19,479 shares of common stock.
- Both transactions were executed at a price of $0 per share as part of director compensation plans.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine regulatory filing regarding director compensation that does not signal a change in company strategy or financial health.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Director elected to receive deferred stock units in lieu of cash, demonstrating long-term commitment to the company.
Negatives
- None identified.
Risks
- Market volatility affecting the value of equity-based compensation.
- Vesting conditions tied to future dates and company performance.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on director compensation and equity ownership.
Management Comments
- The director elected to receive fully vested deferred stock units in lieu of 100% of the cash retainer.
Industry Context
StockSavvy.ai notes that this is a standard regulatory disclosure regarding director compensation, reflecting common corporate governance practices where board members receive equity to align with shareholder interests.
Comparison to Industry Standards
- The use of RSU and deferred stock unit plans for non-employee directors is consistent with standard practices among S&P 500 healthcare technology companies.
- The election to take equity in lieu of cash is a common practice among board members to demonstrate confidence in long-term company value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Election | Director elected to receive deferred stock units in lieu of cash retainer. | 05/07/2026 | Increases director equity alignment with shareholders. |
Stakeholder Impact
- Shareholders benefit from increased alignment between board members and company performance.
Next Steps
- Vesting of restricted stock units on the earlier of the next annual meeting or May 7, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/07/2026 | Date of the earliest transaction involving stock awards. |
| 05/07/2027 | Vesting date for the restricted stock units if the annual meeting has not occurred. |
Keywords
GE HealthCare, GEHC, Director Compensation, Insider Transaction, Form 4, Equity Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.